Journal article
Antiplatelet therapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Key messages for clinical practice.
Abstract
Should we interrupt antiplatelet therapy (acetylsalicylic acid [ASA] alone or in combination with clopidogrel) in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal (GI) procedures? The relevant evidence was critically appraised in a recent White Paper from the American College of Gastroenterology and the American College of Cardiology. Clinicians need to qualify and compare 2 competing risks: …
Authors
Leontiadis GI; Tse F; Howden CW
Journal
Polish Archives of Internal Medicine, Vol. 120, No. 4, pp. 143–147
Publisher
"Medycyna Praktyczna" Spolka Jawna
Publication Date
April 2010
DOI
10.20452/pamw.911
ISSN
0032-3772